Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 9 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 9 |
NetGPI | no | yes: 0, no: 9 |
Term | Name | Level | Count |
---|---|---|---|
GO:0005737 | cytoplasm | 2 | 1 |
GO:0005777 | peroxisome | 6 | 1 |
GO:0005815 | microtubule organizing center | 2 | 1 |
GO:0020015 | glycosome | 7 | 1 |
GO:0036064 | ciliary basal body | 3 | 1 |
GO:0042579 | microbody | 5 | 1 |
GO:0043226 | organelle | 2 | 1 |
GO:0043227 | membrane-bounded organelle | 3 | 1 |
GO:0043229 | intracellular organelle | 3 | 1 |
GO:0043231 | intracellular membrane-bounded organelle | 4 | 1 |
GO:0110165 | cellular anatomical entity | 1 | 2 |
GO:0016020 | membrane | 2 | 1 |
Related structures:
AlphaFold database: A4HME1
Term | Name | Level | Count |
---|---|---|---|
GO:0000166 | nucleotide binding | 3 | 10 |
GO:0003824 | catalytic activity | 1 | 10 |
GO:0005488 | binding | 1 | 10 |
GO:0010181 | FMN binding | 4 | 10 |
GO:0016156 | fumarate reductase (NADH) activity | 5 | 5 |
GO:0016491 | oxidoreductase activity | 2 | 10 |
GO:0016627 | oxidoreductase activity, acting on the CH-CH group of donors | 3 | 6 |
GO:0016628 | oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor | 4 | 5 |
GO:0032553 | ribonucleotide binding | 3 | 10 |
GO:0036094 | small molecule binding | 2 | 10 |
GO:0043167 | ion binding | 2 | 10 |
GO:0043168 | anion binding | 3 | 10 |
GO:0097159 | organic cyclic compound binding | 2 | 10 |
GO:0097367 | carbohydrate derivative binding | 2 | 10 |
GO:1901265 | nucleoside phosphate binding | 3 | 10 |
GO:1901363 | heterocyclic compound binding | 2 | 10 |
GO:0000104 | succinate dehydrogenase activity | 4 | 1 |
GO:0008177 | succinate dehydrogenase (ubiquinone) activity | 5 | 1 |
GO:0016635 | oxidoreductase activity, acting on the CH-CH group of donors, quinone or related compound as acceptor | 4 | 1 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 162 | 166 | PF00656 | 0.314 |
CLV_NRD_NRD_1 | 153 | 155 | PF00675 | 0.314 |
CLV_NRD_NRD_1 | 229 | 231 | PF00675 | 0.310 |
CLV_NRD_NRD_1 | 44 | 46 | PF00675 | 0.693 |
CLV_NRD_NRD_1 | 482 | 484 | PF00675 | 0.349 |
CLV_NRD_NRD_1 | 62 | 64 | PF00675 | 0.305 |
CLV_PCSK_KEX2_1 | 155 | 157 | PF00082 | 0.314 |
CLV_PCSK_KEX2_1 | 44 | 46 | PF00082 | 0.559 |
CLV_PCSK_KEX2_1 | 482 | 484 | PF00082 | 0.353 |
CLV_PCSK_KEX2_1 | 62 | 64 | PF00082 | 0.305 |
CLV_PCSK_PC1ET2_1 | 155 | 157 | PF00082 | 0.314 |
CLV_PCSK_SKI1_1 | 377 | 381 | PF00082 | 0.333 |
CLV_PCSK_SKI1_1 | 433 | 437 | PF00082 | 0.349 |
CLV_PCSK_SKI1_1 | 66 | 70 | PF00082 | 0.528 |
CLV_PCSK_SKI1_1 | 9 | 13 | PF00082 | 0.610 |
CLV_Separin_Metazoa | 120 | 124 | PF03568 | 0.476 |
DEG_APCC_DBOX_1 | 183 | 191 | PF00400 | 0.310 |
DOC_CKS1_1 | 450 | 455 | PF01111 | 0.349 |
DOC_CYCLIN_yClb1_LxF_4 | 377 | 383 | PF00134 | 0.310 |
DOC_MAPK_gen_1 | 278 | 287 | PF00069 | 0.402 |
DOC_MAPK_MEF2A_6 | 278 | 287 | PF00069 | 0.402 |
DOC_PP4_FxxP_1 | 139 | 142 | PF00568 | 0.402 |
DOC_PP4_FxxP_1 | 450 | 453 | PF00568 | 0.349 |
DOC_USP7_MATH_1 | 77 | 81 | PF00917 | 0.668 |
DOC_USP7_UBL2_3 | 14 | 18 | PF12436 | 0.548 |
DOC_USP7_UBL2_3 | 373 | 377 | PF12436 | 0.310 |
DOC_WW_Pin1_4 | 164 | 169 | PF00397 | 0.314 |
DOC_WW_Pin1_4 | 449 | 454 | PF00397 | 0.314 |
DOC_WW_Pin1_4 | 462 | 467 | PF00397 | 0.314 |
DOC_WW_Pin1_4 | 476 | 481 | PF00397 | 0.349 |
LIG_14-3-3_CanoR_1 | 184 | 193 | PF00244 | 0.326 |
LIG_14-3-3_CanoR_1 | 198 | 203 | PF00244 | 0.379 |
LIG_14-3-3_CanoR_1 | 340 | 348 | PF00244 | 0.402 |
LIG_14-3-3_CanoR_1 | 44 | 54 | PF00244 | 0.546 |
LIG_Actin_WH2_2 | 54 | 72 | PF00022 | 0.474 |
LIG_Clathr_ClatBox_1 | 287 | 291 | PF01394 | 0.314 |
LIG_deltaCOP1_diTrp_1 | 134 | 139 | PF00928 | 0.402 |
LIG_FHA_1 | 265 | 271 | PF00498 | 0.470 |
LIG_FHA_1 | 296 | 302 | PF00498 | 0.314 |
LIG_FHA_1 | 308 | 314 | PF00498 | 0.314 |
LIG_FHA_1 | 409 | 415 | PF00498 | 0.456 |
LIG_FHA_1 | 450 | 456 | PF00498 | 0.314 |
LIG_FHA_1 | 493 | 499 | PF00498 | 0.314 |
LIG_FHA_2 | 122 | 128 | PF00498 | 0.402 |
LIG_FHA_2 | 411 | 417 | PF00498 | 0.470 |
LIG_LIR_Apic_2 | 137 | 142 | PF02991 | 0.402 |
LIG_LIR_Apic_2 | 310 | 315 | PF02991 | 0.315 |
LIG_LIR_Nem_3 | 416 | 420 | PF02991 | 0.347 |
LIG_LRP6_Inhibitor_1 | 178 | 184 | PF00058 | 0.476 |
LIG_PCNA_yPIPBox_3 | 192 | 203 | PF02747 | 0.346 |
LIG_PCNA_yPIPBox_3 | 503 | 514 | PF02747 | 0.317 |
LIG_Pex14_1 | 135 | 139 | PF04695 | 0.402 |
LIG_Pex14_2 | 29 | 33 | PF04695 | 0.584 |
LIG_Pex14_2 | 375 | 379 | PF04695 | 0.310 |
LIG_SH2_CRK | 364 | 368 | PF00017 | 0.402 |
LIG_SH2_STAT3 | 218 | 221 | PF00017 | 0.476 |
LIG_SH2_STAT3 | 257 | 260 | PF00017 | 0.402 |
LIG_SH2_STAT5 | 182 | 185 | PF00017 | 0.402 |
LIG_SH2_STAT5 | 312 | 315 | PF00017 | 0.349 |
LIG_SH2_STAT5 | 364 | 367 | PF00017 | 0.402 |
LIG_SH2_STAT5 | 447 | 450 | PF00017 | 0.314 |
LIG_SH2_STAT5 | 457 | 460 | PF00017 | 0.314 |
LIG_SH3_1 | 24 | 30 | PF00018 | 0.588 |
LIG_SH3_2 | 19 | 24 | PF14604 | 0.586 |
LIG_SH3_2 | 27 | 32 | PF14604 | 0.530 |
LIG_SH3_3 | 158 | 164 | PF00018 | 0.402 |
LIG_SH3_3 | 16 | 22 | PF00018 | 0.646 |
LIG_SH3_3 | 24 | 30 | PF00018 | 0.596 |
LIG_SH3_3 | 300 | 306 | PF00018 | 0.314 |
LIG_SH3_3 | 478 | 484 | PF00018 | 0.358 |
LIG_UBA3_1 | 199 | 206 | PF00899 | 0.476 |
LIG_WRC_WIRS_1 | 136 | 141 | PF05994 | 0.402 |
MOD_CDK_SPxK_1 | 476 | 482 | PF00069 | 0.310 |
MOD_CDK_SPxxK_3 | 476 | 483 | PF00069 | 0.310 |
MOD_CK1_1 | 126 | 132 | PF00069 | 0.314 |
MOD_CK1_1 | 263 | 269 | PF00069 | 0.349 |
MOD_CK1_1 | 307 | 313 | PF00069 | 0.349 |
MOD_CK1_1 | 341 | 347 | PF00069 | 0.314 |
MOD_CK1_1 | 357 | 363 | PF00069 | 0.314 |
MOD_CK2_1 | 410 | 416 | PF00069 | 0.349 |
MOD_CK2_1 | 505 | 511 | PF00069 | 0.314 |
MOD_GlcNHglycan | 110 | 113 | PF01048 | 0.257 |
MOD_GlcNHglycan | 127 | 131 | PF01048 | 0.314 |
MOD_GlcNHglycan | 2 | 5 | PF01048 | 0.530 |
MOD_GlcNHglycan | 223 | 226 | PF01048 | 0.376 |
MOD_GlcNHglycan | 320 | 323 | PF01048 | 0.335 |
MOD_GlcNHglycan | 356 | 359 | PF01048 | 0.450 |
MOD_GlcNHglycan | 466 | 469 | PF01048 | 0.289 |
MOD_GlcNHglycan | 99 | 102 | PF01048 | 0.423 |
MOD_GSK3_1 | 198 | 205 | PF00069 | 0.425 |
MOD_GSK3_1 | 217 | 224 | PF00069 | 0.244 |
MOD_GSK3_1 | 238 | 245 | PF00069 | 0.339 |
MOD_GSK3_1 | 259 | 266 | PF00069 | 0.315 |
MOD_GSK3_1 | 451 | 458 | PF00069 | 0.349 |
MOD_GSK3_1 | 469 | 476 | PF00069 | 0.349 |
MOD_N-GLC_1 | 185 | 190 | PF02516 | 0.441 |
MOD_N-GLC_1 | 307 | 312 | PF02516 | 0.349 |
MOD_N-GLC_1 | 408 | 413 | PF02516 | 0.310 |
MOD_NEK2_1 | 121 | 126 | PF00069 | 0.349 |
MOD_NEK2_1 | 318 | 323 | PF00069 | 0.314 |
MOD_NEK2_1 | 36 | 41 | PF00069 | 0.658 |
MOD_PIKK_1 | 144 | 150 | PF00454 | 0.314 |
MOD_PIKK_1 | 217 | 223 | PF00454 | 0.476 |
MOD_PIKK_1 | 341 | 347 | PF00454 | 0.402 |
MOD_PKA_2 | 318 | 324 | PF00069 | 0.314 |
MOD_Plk_2-3 | 469 | 475 | PF00069 | 0.310 |
MOD_Plk_4 | 249 | 255 | PF00069 | 0.314 |
MOD_Plk_4 | 505 | 511 | PF00069 | 0.314 |
MOD_ProDKin_1 | 164 | 170 | PF00069 | 0.314 |
MOD_ProDKin_1 | 449 | 455 | PF00069 | 0.314 |
MOD_ProDKin_1 | 462 | 468 | PF00069 | 0.314 |
MOD_ProDKin_1 | 476 | 482 | PF00069 | 0.349 |
MOD_SUMO_rev_2 | 224 | 229 | PF00179 | 0.310 |
TRG_DiLeu_BaLyEn_6 | 195 | 200 | PF01217 | 0.476 |
TRG_DiLeu_BaLyEn_6 | 532 | 537 | PF01217 | 0.564 |
TRG_ENDOCYTIC_2 | 364 | 367 | PF00928 | 0.402 |
TRG_ENDOCYTIC_2 | 417 | 420 | PF00928 | 0.349 |
TRG_ENDOCYTIC_2 | 447 | 450 | PF00928 | 0.375 |
TRG_ER_diArg_1 | 24 | 27 | PF00400 | 0.590 |
TRG_ER_diArg_1 | 44 | 46 | PF00400 | 0.443 |
TRG_ER_diArg_1 | 481 | 483 | PF00400 | 0.349 |
TRG_ER_diArg_1 | 61 | 63 | PF00400 | 0.310 |
TRG_Pf-PMV_PEXEL_1 | 123 | 127 | PF00026 | 0.402 |
TRG_Pf-PMV_PEXEL_1 | 281 | 286 | PF00026 | 0.310 |
TRG_Pf-PMV_PEXEL_1 | 44 | 49 | PF00026 | 0.553 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1I5C0 | Leptomonas seymouri | 72% | 90% |
A0A0S4IHN0 | Bodo saltans | 59% | 100% |
A0A0S4KND3 | Bodo saltans | 35% | 100% |
A0A1X0NPF8 | Trypanosomatidae | 36% | 80% |
A0A3S7WPX2 | Leishmania donovani | 35% | 81% |
A0A3S7X915 | Leishmania donovani | 79% | 100% |
A0A422MX37 | Trypanosoma rangeli | 62% | 83% |
A0R4S9 | Mycolicibacterium smegmatis (strain ATCC 700084 / mc(2)155) | 25% | 95% |
A4HME0 | Leishmania braziliensis | 98% | 100% |
A4HTA6 | Leishmania infantum | 35% | 96% |
A4IB13 | Leishmania infantum | 79% | 100% |
B2GCE0 | Limosilactobacillus fermentum (strain NBRC 3956 / LMG 18251) | 27% | 88% |
C8WLE3 | Eggerthella lenta (strain ATCC 25559 / DSM 2243 / CCUG 17323 / JCM 9979 / KCTC 3265 / NCTC 11813 / VPI 0255 / 1899 B) | 29% | 90% |
C8WLM1 | Eggerthella lenta (strain ATCC 25559 / DSM 2243 / CCUG 17323 / JCM 9979 / KCTC 3265 / NCTC 11813 / VPI 0255 / 1899 B) | 23% | 97% |
D9PU00 | Methanothermobacter marburgensis (strain ATCC BAA-927 / DSM 2133 / JCM 14651 / NBRC 100331 / OCM 82 / Marburg) | 28% | 99% |
E9AEU2 | Leishmania major | 76% | 100% |
E9AL95 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 34% | 81% |
E9B5Z8 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 77% | 100% |
F8DIF2 | Streptococcus parasanguinis (strain ATCC 15912 / DSM 6778 / CIP 104372 / LMG 14537) | 27% | 68% |
F9UNH3 | Lactiplantibacillus plantarum (strain ATCC BAA-793 / NCIMB 8826 / WCFS1) | 29% | 67% |
G4V4G6 | Serratia sp. (strain ATCC 39006) | 29% | 92% |
O06913 | Helicobacter pylori (strain ATCC 700392 / 26695) | 28% | 76% |
O13755 | Schizosaccharomyces pombe (strain 972 / ATCC 24843) | 34% | 100% |
P00363 | Escherichia coli (strain K12) | 29% | 90% |
P0AC41 | Escherichia coli (strain K12) | 31% | 92% |
P0AC42 | Escherichia coli O6:H1 (strain CFT073 / ATCC 700928 / UPEC) | 31% | 92% |
P0AC43 | Escherichia coli O157:H7 | 31% | 92% |
P0C278 | Shewanella frigidimarina | 35% | 95% |
P20922 | Proteus vulgaris | 29% | 91% |
P21375 | Saccharomyces cerevisiae (strain ATCC 204508 / S288c) | 38% | 100% |
P32614 | Saccharomyces cerevisiae (strain ATCC 204508 / S288c) | 38% | 100% |
P44894 | Haemophilus influenzae (strain ATCC 51907 / DSM 11121 / KW20 / Rd) | 27% | 91% |
P64175 | Mycobacterium bovis (strain ATCC BAA-935 / AF2122/97) | 27% | 93% |
P71864 | Mycobacterium tuberculosis (strain ATCC 25618 / H37Rv) | 25% | 96% |
P83223 | Shewanella oneidensis (strain MR-1) | 32% | 91% |
P9WN90 | Mycobacterium tuberculosis (strain CDC 1551 / Oshkosh) | 27% | 93% |
P9WN91 | Mycobacterium tuberculosis (strain ATCC 25618 / H37Rv) | 27% | 93% |
Q07WU7 | Shewanella frigidimarina (strain NCIMB 400) | 35% | 91% |
Q28ED0 | Xenopus tropicalis | 24% | 82% |
Q4QIK9 | Leishmania major | 34% | 100% |
Q6PA58 | Xenopus laevis | 24% | 82% |
Q7D5C1 | Mycobacterium tuberculosis (strain CDC 1551 / Oshkosh) | 25% | 96% |
Q7M827 | Wolinella succinogenes (strain ATCC 29543 / DSM 1740 / LMG 7466 / NCTC 11488 / FDC 602W) | 27% | 89% |
Q801S2 | Xenopus laevis | 24% | 82% |
Q8CVD0 | Shewanella oneidensis (strain MR-1) | 32% | 93% |
Q8DW88 | Streptococcus mutans serotype c (strain ATCC 700610 / UA159) | 28% | 68% |
Q8XQG4 | Ralstonia solanacearum (strain GMI1000) | 25% | 100% |
Q8YXJ6 | Nostoc sp. (strain PCC 7120 / SAG 25.82 / UTEX 2576) | 28% | 94% |
Q8ZQU3 | Salmonella typhimurium (strain LT2 / SGSC1412 / ATCC 700720) | 31% | 92% |
Q92R32 | Rhizobium meliloti (strain 1021) | 27% | 100% |
Q97K95 | Clostridium acetobutylicum (strain ATCC 824 / DSM 792 / JCM 1419 / LMG 5710 / VKM B-1787) | 27% | 100% |
Q9X8N8 | Streptomyces coelicolor (strain ATCC BAA-471 / A3(2) / M145) | 28% | 94% |
Q9Z4P0 | Shewanella frigidimarina (strain NCIMB 400) | 35% | 92% |
Q9ZMP0 | Helicobacter pylori (strain J99 / ATCC 700824) | 28% | 76% |
V3TQ67 | Serratia sp. (strain ATCC 39006) | 28% | 91% |